1. Home
  2. ATYR vs VATE Comparison

ATYR vs VATE Comparison

Compare ATYR & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.78

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$4.54

Market Cap

70.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
VATE
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
70.3M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
ATYR
VATE
Price
$0.78
$4.54
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.6M
14.4K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,000.00
$1,099,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$4.05
52 Week High
$7.29
$13.79

Technical Indicators

Market Signals
Indicator
ATYR
VATE
Relative Strength Index (RSI) 43.35 32.98
Support Level $0.70 $4.76
Resistance Level $0.83 $5.28
Average True Range (ATR) 0.06 0.24
MACD 0.03 -0.07
Stochastic Oscillator 57.87 24.99

Price Performance

Historical Comparison
ATYR
VATE

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: